Shapiro AMJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318–1330. doi: 10.1056/NEJMoa061267
Vertex Pharmaceuticals. Vertex announces positive day 90 data for the first patient in the phase 1/2 clinical trial dosed with VX-880, a novel investigational stem cell-derived therapy for the treatment of type 1 diabetes. October 18, 2021. https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-positive-day-90-data-first-patient-phase-12
ClinicalTrials.gov. A safety, tolerability, and efficacy study of VX-880 in participants with type 1 diabetes. First posted: March 8, 2021; Last update posted: February 17, 2022. Identifier: NCT04786262. https://clinicaltrials.gov/ct2/show/NCT04786262
Kolata, G. A cure for type 1 diabetes? For one man, it seems to have worked. The New York Times November 27, 2021. https://www.nytimes.com/2021/11/27/health/diabetes-cure-stem-cells.html